Trade AstraZeneca ^AZN

Innate Pharma Reports First Quarter 2026 Business Update and Financial Results

Innate Pharma présente l'avancée de son portefeuille et ses résultats financiers du premier trimestre 2026

Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update

Implementing AI in workflows: One step at a time

UK junior minister Miatta Fahnbulleh resigns, urges PM Starmer to set exit timetable

AstraZeneca PLC (LON:AZN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - Daily Political

AstraZeneca PLC (AZN) Stock Falls as FDA Panel Votes Against New Cancer Drug

Early FMISO PET changes as exploratory predictors of immune checkpoint inhibitor response in advanced lung cancer: a pilot study

PRIMECAP Management's Strategic Moves: AstraZeneca PLC Exits with a -2.57% Impact

Cellectis Reports Financial Results for the First Quarter 2026

Cellectis publie ses résultats financiers du premier trimestre 2026

CDT Equity Advances AstraZeneca PLC (AZN)'s AZD5904 Into PCT Patent Protection Stage

Drug companies involved in TrumpRx boosted lobbying by 23% ahead of program's launch

Astrazeneca Plc $AZN Position Boosted by NewEdge Wealth LLC

Mitsubishi UFJ Asset Management Co. Ltd. Raises Holdings in Astrazeneca Plc $AZN - Stock Observer

Positron-emission tomography as a predictor of response to first-line cyclin-dependent kinase 4/6 inhibitors in patients with metastatic ER-positive HER2-negative breast cancer

5 Best Cancer Stocks to Buy for the Long Term

The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial

Genmab A/S (0MGB) Receives a Buy from Goldman Sachs

Denali Advisors LLC Raises Stock Position in Astrazeneca Plc $AZN - Zolmax

Channel Wealth LLC Sells 10,555 Shares of Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Stake Boosted by Ethic Inc. - Daily Political

Risk factors and metastatic sites in HER2-positive breast cancer with pathological complete response

/DISREGARD RELEASE: Pactum/ | Morningstar

Darren Sissons' Past Picks: AstraZeneca, Canadian Pacific Kansas City & Linde Plc - BNN Bloomberg

Astrazeneca FY2026 EPS Estimate Lowered by Erste Group Bank - Stock Observer

14,706 Shares in Astrazeneca Plc $AZN Acquired by RFG Advisory LLC - Stock Observer

AZN's AZD5904 Advances to Patent Cooperation Treaty Stage

Astrazeneca Plc $AZN Shares Purchased by MGO One Seven LLC - Daily Political

From R&D to M&A: Big Pharmas showcase 'measurable impact' of AI

Pactum To Showcase Agentic AI Procurement Solutions On Stage with AstraZeneca at Coupa Inspire 2026 | Morningstar

AstraZeneca PLC (LON:AZN) Given Average Recommendation of "Moderate Buy" by Brokerages

Principal Financial Group Inc. Reduces Holdings in Astrazeneca Plc $AZN - Stock Observer

Newcomer anti-IL-33 makes strides in COPD

Ken Fisher's Strategic Moves: AstraZeneca PLC Leads the Portfolio Additions

6 Pharma Dividend Stocks Yielding Up to 6.44% - and They've Survived Every Market Crash

Providence First Trust Co Takes $648,000 Position in Astrazeneca Plc $AZN

Indivisible Partners Acquires New Shares in Astrazeneca Plc $AZN - Stock Observer

AstraZeneca (LON:AZN) Given Sell Rating at Deutsche Bank Aktiengesellschaft - Daily Political

Manufacturing Stocks To Research - May 5th - Zolmax

Manufacturing Stocks To Research - May 5th - Daily Political

M&T Bank Corp Decreases Stock Holdings in Astrazeneca Plc $AZN - Zolmax

Benjamin Edwards Inc. Trims Stake in Astrazeneca Plc $AZN

Wealthfront Advisers LLC Invests $422,000 in Astrazeneca Plc $AZN - Daily Political

Sigma Planning Corp Buys 5,917 Shares of Astrazeneca Plc $AZN - Daily Political

The transformative role of SBRT in the management of spinal metastases

Strong Results and Improved Guidance Lifted AstraZeneca PLC (AZN)

Mixed FDA Votes On Truqap And Camizestrant Refocus AstraZeneca Oncology Risk

Is AstraZeneca PLC (AZN) A Good Stock To Buy Now?

Is It Too Late To Consider AstraZeneca (LSE:AZN) After Its Strong Five Year Run?

With £9,633.30 to invest, are these the best UK stocks to buy now?

US Bancorp DE Acquires 16,922 Shares of Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Shares Sold by D.A. Davidson & CO.

Wall Street Zen Upgrades Astrazeneca (NYSE:AZN) to Buy

A Fresh Look At AstraZeneca (LSE:AZN) Valuation After Recent Share Price Pullback

Manufacturing Stocks To Consider - April 30th - Stock Observer

AstraZeneca Faces Setback as FDA Advisory Panel Rejects Cancer Drug (AZN)

UK's FTSE 100 Closes Lower; NatWest, AstraZeneca Shares Down

Top Manufacturing Stocks To Watch Now - May 1st - Daily Political

Futures Rise, Oil Slides On Iran Ceasefire Optimism After Best Month For Stocks Since 2020

FTSE 100 drops in thin trading as NatWest, AstraZeneca weigh

JPY breaches Thursday low in potential further intervention, bourses in thin trade amid holiday, US futures lacklustre - US Market Open

Astrazeneca (NYSE:AZN) Upgraded to Buy at Barclays - Daily Political

Astrazeneca (NYSE:AZN) Given "Sell" Rating at Deutsche Bank Aktiengesellschaft - Daily Political

Head-To-Head Contrast: AstraZeneca (OTCMKTS:AZNCF) vs. Otsuka (OTCMKTS:OTSKY) - Stock Observer

TRUQAP® (capivasertib) recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer

Astrazeneca Plc $AZN Shares Acquired by GC Wealth Management RIA LLC - Zolmax

Promising Manufacturing Stocks To Consider - April 29th - Zolmax

AstraZeneca (AZN) Faces FDA Advisory Committee Vote on Camizestrant

AstraZeneca (AZN) Faces Setback as FDA Advisory Panel Questions Drug's Benefit

AstraZeneca Is a Buy as More Than 20 Phase III Readouts Loom

Astrazeneca Plc $AZN Shares Acquired by GC Wealth Management RIA LLC - Daily Political

FDA panel votes against backing AstraZeneca's breast cancer drug - Yahoo News Canada

Astrazeneca (NYSE:AZN) Rating Increased to Buy at DZ Bank - Stock Observer

Jennison Associates LLC Has $309.15 Million Holdings in Astrazeneca Plc $AZN

Brokers Set Expectations for Astrazeneca FY2026 Earnings

AI will play key role in detecting cancer, AstraZeneca CEO says

AstraZeneca invests £300 million in UK in boost for Starmer - The Business Times

DZ Bank Upgrades Astrazeneca (NYSE:AZN) to Buy - Daily Political

Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones | Morningstar

If the stock market crashes, I'm keen to buy these world-class FTSE 100 shares

SKF commits to a sovereign AI future through strategic partnership with Sferical AI

Unique trial strategy muddies the ODAC waters for camizestrant | BioWorld

Astrazeneca exercises option for Pinetree's PTX-299 | BioWorld

Astrazeneca Q1 Earnings Call Highlights

Sun Pharmaceuticals Industries Ltd Option Chain & Strike Prices | IIFL Capital

Pinetree Therapeutics Announces Exercise of Option to License EGFR Degrader Program by AstraZeneca | Morningstar

AstraZeneca (AZN) Announces ВЈ300 Million Investment in UK Follow

AstraZeneca (AZN) and GSK Report Strong Q1 Earnings Amid Pricing Policy Concerns

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

TEM stock price analysis: Why Tempus AI Stock Up Today?

FTSE 100 index near one-month lows as global sentiment sours

Moderna share price jumps as Oppenheimer upgrades stock

Week ahead: RBA poised to hike?

FTSE 100 Index: London stocks start week sharply lower

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk